Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Using missing data methods in genetic studies with missing mutation status.

T Leong1, S R Lipsitz, J G Ibrahim

  • 1Department of Biostatistical Science, Dana Farber Cancer Institute, Boston, MA 02115, USA.

Statistics in Medicine
|March 10, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Controversies in upper GI oncology: role of radiotherapy in non-metastatic gastroesophageal adenocarcinoma.

ESMO gastrointestinal oncology·2026
Same author

Multidisciplinary discussion in upper GI tumours: management of a patient with a locally advanced Siewert II gastroesophageal junctional adenocarcinoma.

ESMO gastrointestinal oncology·2026
Same author

Multidisciplinary discussion on upper GI tumours: management of a patient with a middle-third locally advanced squamous-cell carcinoma.

ESMO gastrointestinal oncology·2026
Same author

Subacute pericardial tamponade presenting with hypertension.

Irish medical journal·2025
Same author

ESMO Clinical Practice Guideline interim update on the treatment of locally advanced oesophageal and oesophagogastric junction adenocarcinoma and metastatic squamous-cell carcinoma.

ESMO open·2025
Same author

Neoadjuvant Chemoradiotherapy in Locally Advanced and Locally Recurrent Colon Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

This study introduces a maximum likelihood method to estimate odds ratios for RAS gene mutations and disease cell types, even with incomplete genetic data. The approach improves accuracy by including all patients, unlike methods that exclude those with partial genetic information.

Area of Science:

  • Genetics
  • Biostatistics
  • Oncology

Background:

  • Investigating the association between genetic mutations and disease outcomes is crucial.
  • The RAS gene family is frequently implicated in various cancers.
  • Accurate estimation of odds ratios is vital for understanding genotype-phenotype correlations.

Purpose of the Study:

  • To develop a statistical method for estimating the odds ratio between RAS genetic mutation status and disease cell type.
  • To address challenges posed by incomplete genetic data in mutation analysis.
  • To compare the proposed method with existing approaches for handling missing genetic information.

Main Methods:

  • Utilizing maximum likelihood (ML) estimation with a 2(6) multinomial distribution.
  • Cross-classifying binary mutation status at five gene locations by binary disease cell type.

Related Experiment Videos

  • Employing the Expectation-Maximization (EM) algorithm to handle missing data and estimate parameters.

    • Main Results:

    • The proposed ML method effectively incorporates all patients, including those with incomplete genetic data.
    • It treats unassessed gene locations as missing data, providing a more comprehensive analysis.
    • Comparison with complete case analysis and a clinical exclusion method demonstrates the ML approach's advantages.

    Conclusions:

    • Maximum likelihood with a multinomial distribution and the EM algorithm offers a robust solution for odds ratio estimation with incomplete genetic data.
    • This method enhances the ability to study gene mutation associations with disease types.
    • The approach is more inclusive and statistically sound than methods that exclude patients with partial data.